Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.77
-0.61 (-7.28%)
At close: Dec 5, 2025, 4:00 PM EST
7.81
+0.04 (0.51%)
After-hours: Dec 5, 2025, 4:53 PM EST
Addex Therapeutics Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -6.1 | 7.06 | -10.56 | -20.8 | -15.35 | -12.86 | |
| Depreciation & Amortization | 0.03 | 0.19 | 0.01 | 0.01 | 0.35 | 0.38 | |
| Loss (Gain) on Equity Investments | 3.73 | 2.18 | - | - | - | - | |
| Stock-Based Compensation | 0.09 | 0.18 | 0.28 | 0.68 | 1.34 | 1.46 | |
| Other Operating Activities | -0.04 | -0.18 | 0.29 | 0.2 | -0.28 | 0.66 | |
| Change in Accounts Receivable | 0.47 | 0.13 | 0.45 | -0.27 | -0.26 | 0.05 | |
| Change in Accounts Payable | 0.29 | -1.15 | -0.61 | -0.43 | 0.88 | -1.59 | |
| Change in Unearned Revenue | - | -0.04 | 0.32 | - | -0.82 | -0.46 | |
| Change in Other Net Operating Assets | 0.08 | -0.18 | 0.06 | 0.86 | -0.57 | 0.17 | |
| Operating Cash Flow | -1.58 | -5.37 | -7.99 | -16.44 | -14.71 | -12.18 | |
| Capital Expenditures | - | -0 | -0.01 | -0 | -0.03 | -0.06 | |
| Investment in Securities | -0.29 | - | - | 0 | 0 | - | |
| Other Investing Activities | -0.41 | 4.65 | - | - | - | - | |
| Investing Cash Flow | -0.69 | 4.65 | -0.01 | 0 | -0.03 | -0.06 | |
| Long-Term Debt Repaid | - | -0.07 | -0.28 | -0.29 | -0.31 | -0.37 | |
| Net Debt Issued (Repaid) | -0.01 | -0.07 | -0.28 | -0.29 | -0.31 | -0.37 | |
| Issuance of Common Stock | 1.15 | 0.24 | 2.35 | 1.68 | 13.96 | 0.72 | |
| Repurchase of Common Stock | -0.03 | -0.03 | -0.05 | -0.31 | -0.39 | - | |
| Other Financing Activities | -0.01 | -0.04 | 3.24 | 2.02 | 3.14 | -0.31 | |
| Financing Cash Flow | 1.11 | 0.1 | 5.26 | 3.1 | 16.4 | 0.05 | |
| Foreign Exchange Rate Adjustments | 0 | 0.1 | -0.36 | -0.2 | 0.12 | -0.65 | |
| Net Cash Flow | -1.16 | -0.52 | -3.09 | -13.53 | 1.79 | -12.84 | |
| Free Cash Flow | -1.58 | -5.37 | -8 | -16.44 | -14.74 | -12.24 | |
| Free Cash Flow Margin | -993.65% | -1310.80% | -494.64% | -1137.59% | -467.34% | -315.52% | |
| Free Cash Flow Per Share | -0.01 | -0.06 | -0.11 | -0.36 | -0.43 | -0.46 | |
| Cash Interest Paid | 0 | 0.01 | 0.02 | 0.05 | 0.06 | 0.07 | |
| Levered Free Cash Flow | -0.6 | -3.01 | -0.99 | -6.19 | -8.2 | -7.85 | |
| Unlevered Free Cash Flow | -0.6 | -3.01 | -0.99 | -6.17 | -8.16 | -7.81 | |
| Change in Working Capital | 0.83 | -1.23 | 0.21 | 0.16 | -0.76 | -1.82 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.